We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $860B
1-Year Est. Return 41.15%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+41.15%
3 Year Est. Return
+122.29%
5 Year Est. Return
+158.18%
10 Year Est. Return
+652.62%
AUM
$447B
AUM Growth
+$29B
Cap. Flow
-$5.27B
Cap. Flow %
-1.18%
Top 10 Hldgs %
16.98%
Holding
4,386
New
134
Increased
1,479
Reduced
2,453
Closed
124

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$431M
2
TFC icon
Truist Financial
TFC
+$346M
3
BABA icon
Alibaba
BABA
+$238M
4
NOW icon
ServiceNow
NOW
+$228M
5
CTVA icon
Corteva
CTVA
+$156M

Sector Composition

Rank Sector Weight
1 Technology 18.13%
2 Financials 14.48%
3 Healthcare 12.77%
4 Consumer Discretionary 9.62%
5 Industrials 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOTS
2926
DELISTED
Adesto Technologies Corp
IOTS
$2.79M ﹤0.01%
327,642
+5,310
+2% +$41.7K
BCML icon
2927
BayCom
BCML
$339M
$2.78M ﹤0.01%
122,434
+10,433
+9% +$231K
BEST
2928
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$2.78M ﹤0.01%
25,022
+24,241
+3,104% +$2.66M
SYRS
2929
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.77M ﹤0.01%
40,150
-2,535
-6% -$154K
IGMS
2930
DELISTED
IGM Biosciences
IGMS
$2.77M ﹤0.01%
+72,677
New +$1.83M
NATH icon
2931
Nathan's Famous
NATH
$397M
$2.75M ﹤0.01%
38,874
-579
-1% -$42.7K
WLFC icon
2932
Willis Lease Finance
WLFC
$1.15B
$2.75M ﹤0.01%
140,043
+1,779
+1% +$34.7K
TRNS icon
2933
Transcat
TRNS
$888M
$2.75M ﹤0.01%
86,265
-1,166
-1% -$35.5K
LBC
2934
DELISTED
Luther Burbank Corporation Common Stock
LBC
$2.74M ﹤0.01%
237,562
-4,445
-2% -$50.6K
ODC icon
2935
Oil-Dri
ODC
$1.27B
$2.73M ﹤0.01%
150,828
+5,110
+4% +$89.7K
CHMI
2936
Cherry Hill Mortgage Investment Corp
CHMI
$108M
$2.73M ﹤0.01%
187,231
-1,286
-0.7% -$18K
SPNE
2937
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$2.71M ﹤0.01%
225,593
+6,135
+3% +$74.9K
SRRK icon
2938
Scholar Rock
SRRK
$6.46B
$2.7M ﹤0.01%
204,878
-783
-0.4% -$7.51K
IJT icon
2939
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.43B
$2.7M ﹤0.01%
27,904
-2,514
-8% -$232K
BCH icon
2940
Banco de Chile
BCH
$20.5B
$2.69M ﹤0.01%
128,371
-11,699
-8% -$285K
CWBC
2941
Community West Bancshares
CWBC
$706M
$2.69M ﹤0.01%
124,280
-5,418
-4% -$113K
PAM icon
2942
Pampa Energía
PAM
$4.24B
$2.69M ﹤0.01%
163,490
-140,972
-46% -$2.14M
VTOL icon
2943
Bristow Group
VTOL
$1.38B
$2.68M ﹤0.01%
131,962
-573
-0.4% -$11.4K
TACO
2944
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$2.68M ﹤0.01%
339,489
-18,173
-5% -$147K
SCZ icon
2945
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$2.68M ﹤0.01%
42,992
+21,672
+102% +$1.3M
CBMG
2946
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$2.67M ﹤0.01%
164,081
+3,806
+2% +$63.5K
GMAB icon
2947
Genmab
GMAB
$19.3B
$2.66M ﹤0.01%
119,198
+55,069
+86% +$1.2M
VHC icon
2948
VirnetX Holding Corp
VHC
$64.8M
$2.66M ﹤0.01%
34,976
-750
-2% -$75.3K
BELFB
2949
Bel Fuse Inc Class B
BELFB
$4.13B
$2.65M ﹤0.01%
129,464
-7,898
-6% -$130K
TLRD
2950
DELISTED
Tailored Brands, Inc.
TLRD
$2.65M ﹤0.01%
640,948
-17,775
-3% -$83.7K

Similar funds

Northern Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
  • Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
  • Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
  • Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
  • Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
  • Northern Trust opened 134 new positions and closed 124 in Q4 2019.
  • Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.

Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.